OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
Companies/Materials/CE
CENYSE—63

Celanese Corp

Specialty ChemicalsVerified

Celanese Corp (CE) is currently classified as Chemicals within Specialty Chemicals (Basic Materials). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: total assets 21,695,000,000 USD, total equity 4,049,000,000, short-term debt 0, long-term debt 11,394,000,000. Net cash position is approximately -11,394,000,000 USD. Profitability profile: revenue 9,544,000,000, gross profit 1,952,000,000, operating income -786,000,000, net income -1,165,000,000. Return on equity ~-28.8%. Return on assets ~-5.4%. Operating-cash-flow to net-income ratio is -0.98. Risk profile from automated assessment: liquidity risk medium, dilution risk medium. Flags: Net cash is negative after subtracting total debt.; Source documents mention dilution or offering risk..

30-day price · CE-0.20 (-0.4%)
Low$54.92High$70.70Close$56.80As of15 May, 00:00 UTC
Profile
CompanyCelanese Corp
ExchangeNYSE
TickerCE
CIK0001306830
SICPlastic Material, Synth Resin/Rubber, Cellulos (No Glass)
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Celanese Corp is classified under Basic Materials / Specialty Chemicals and appears not currently profitable on the latest normalized snapshot.

Classification. Classification confidence is 0.92 based on verified market data; matched terms: Specialty Chemicals, Chemicals, Basic Materials.

Celanese Corp (CE) is currently classified as Chemicals within Specialty Chemicals (Basic Materials). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: total assets 21,695,000,000 USD, total equity 4,049,000,000, short-term debt 0, long-term debt 11,394,000,000. Net cash position is approximately -11,394,000,000 USD. Profitability profile: revenue 9,544,000,000, gross profit 1,952,000,000, operating income -786,000,000, net income -1,165,000,000. Return on equity ~-28.8%. Return on assets ~-5.4%. Operating-cash-flow to net-income ratio is -0.98. Risk profile from automated assessment: liquidity risk medium, dilution risk medium. Flags: Net cash is negative after subtracting total debt.; Source documents mention dilution or offering risk..
Key takeaways
  • Return on equity is about -28.8%.
  • Debt to equity is about 2.81x.
  • Companyfacts coverage was partial; recent filing facts backfilled shares_outstanding_basic.
Financial snapshot
PeriodFY2025
CurrencyUSD
Revenue$9.54B
Gross profit$1.95B
Operating income-$786.0M
Net income-$1.17B
R&D$125.0M
SG&A—
D&A$760.0M
SBC$24.0M
Operating cash flow$1.15B
CapEx$343.0M
Free cash flow$803.0M
Total assets$21.70B
Total liabilities—
Total equity$4.05B
Cash & equivalents—
Long-term debt$11.39B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$9.54B-$786.0M-$1.17B$803.0M
FY2024$10.28B-$697.0M-$1.52B$531.0M
FY2025$10.27B-$720.0M-$1.54B$531.0M
FY2023$10.94B$1.69B$1.96B$1.33B
FY2024$10.94B$1.69B$1.96B$1.33B
PeriodGross %Op %Net %FCF %
FY2025————
FY2024————
FY2025————
FY2023————
FY2024————
PeriodAssetsEquityCashDebt
FY2025$21.70B$4.05B——
FY2024$22.86B$5.17B——
FY2025$22.84B$5.13B——
FY2023$26.60B$7.09B——
FY2024$26.60B$7.09B——
PeriodOCFCapExFCFSBC
FY2025$1.15B$343.0M$803.0M$24.0M
FY2024$966.0M$435.0M$531.0M$32.0M
FY2025$966.0M$435.0M$531.0M$32.0M
FY2023$1.90B$568.0M$1.33B$40.0M
FY2024$1.90B$568.0M$1.33B$40.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q3 2025$7.34B-$879.0M-$1.18B$635.0M
Q2 2025$4.92B$401.0M$178.0M$252.0M
Q1 2025$2.39B$168.0M-$21.0M-$65.0M
Q1 2025————
PeriodGross %Op %Net %FCF %
Q3 2025————
Q2 2025————
Q1 2025————
Q1 2025————
PeriodAssetsEquityCashDebt
Q3 2025$22.17B$3.95B——
Q2 2025$23.71B$5.28B——
Q1 2025$23.20B$5.19B——
Q1 2025$22.86B$5.17B——
PeriodOCFCapExFCFSBC
Q3 2025$894.0M$259.0M$635.0M$19.0M
Q2 2025$447.0M$195.0M$252.0M$12.0M
Q1 2025$37.0M$102.0M-$65.0M$5.0M
Q1 2025————
Valuation
Market price—
Market cap—
Enterprise value—
P/E—
Reported non-GAAP P/E—
EV/Revenue—
EV/Op income—
EV/OCF—
P/B—
P/Tangible book—
Tangible book—
Net cash-$11.39B
Current ratio1.6
Debt/Equity2.8
ROA-5.4%
ROE-28.8%
Cash conversion-98.0%
CapEx/Revenue3.6%
SBC/Revenue0.2%
Asset intensity0.2
Dilution ratio0.0%
Risk assessment
Dilution riskMedium
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
  • Source documents mention dilution or offering risk.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricCEActivity
Op margin-8.2%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-12.2%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin20.5%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.3%1.1% medp25 0.5% · p75 1.3%top quartile
CapEx / revenue3.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity281.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
market data ESG controversies score100.0
market data ESG governance pillar82.1
market data ESG social pillar64.3
market data insider trading score6.0
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
SEC filingstype companyfacts · CIK 0001306830 · 622 us-gaap concepts
data.sec.gov/CIK0001306830.json
2026-05-01 12:34 UTC#dec05a11
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 12:35 UTCJob: a1780996